New Type 2 Diabetes Drug Onglyza Approved
The FDA has approved Onglyza, a new once-daily oral tablet for the treatment of type-2 diabetes. Onglyza is in the same drug class as Januvia, approved in 2006.
See the original post here:
New Type 2 Diabetes Drug Onglyza Approved
